Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment

News
25 July 2016
New & experimental HIV treatments

Long-acting injectable drugs work well for HIV maintenance therapy

News
22 July 2016
The search for a cure

HIV will only be cured with combinations too, conference delegates hear

News
20 July 2016
New & experimental HIV treatments

Treatment Action Group: Pipeline Report 2016

Editor's pick
Treatment Action Group
15 July 2016
New & experimental HIV treatments

New integrase inhibitor bictegravir looks promising in early studies

News
6 July 2016
New & experimental HIV treatments

The HIV Treatment Pipeline

Editor's pick
Poz
28 June 2016
New & experimental HIV treatments

PRO 140 antibody injections maintain viral suppression in phase 2 study

News
28 June 2016
New & experimental HIV treatments

Gilead’s single tablet regimen Odefsey receives European marketing approval for HIV treatment

Editor's pick
PharmaBiz
27 June 2016
New & experimental HIV treatments

Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study

Editor's pick
The Body
21 June 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
Access to healthcare

Botswana gets GSK's modern HIV drug in largest ever Africa tender

Editor's pick
Reuters
3 June 2016
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV

Editor's pick
Gilead press release
25 April 2016
Access to healthcare

ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

Editor's pick
ViiV Healthcare press release
25 April 2016
New & experimental HIV treatments

U.S. Food and Drug Administration Approves Descovy® (Emtricitabine, Tenofovir Alafenamide), Gilead’s Third TAF-Based HIV Therapy

Editor's pick
Gilead press release
5 April 2016
New & experimental HIV treatments

Long-acting oral antiretroviral MK-8591 could represent 'paradigm shift' in HIV treatment and prophylaxis

News
1 April 2016
The search for a cure

Gene therapy snips HIV out of infected cells and makes uninfected cells resistant

News
30 March 2016
New & experimental HIV treatments

Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study

News
18 March 2016
PrEP science

Maraviroc may work as PrEP in combination with another drug – but probably not by itself

News
3 March 2016
PrEP

San Francisco HIV providers: What did you learn at CROI 2016?

Editor's pick
BETA blog
3 March 2016
New & experimental HIV treatments

ABIVAX’s Novel Approach to Treat HIV Demonstrates Safety and Preliminary Anti-viral Activity in Phase IIa

Editor's pick
Abivax press release
2 March 2016
New & experimental HIV treatments

Gilead Sciences Announces FDA Approval of Odefsey as HIV-1 Treatment in Certain Patients

Editor's pick
Gilead press release
2 March 2016
The search for a cure

Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption

News
29 February 2016
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine/Tenofovir Alafenamide) for the Treatment of HIV

Editor's pick
Gilead press release
26 February 2016
The search for a cure

Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016

Editor's pick
Sangamo Biosciences press release
26 February 2016